.jetcityimage/iStock Content by means of Getty Images Morgan Stanley has actually opted for Eli Lilly (NYSE: LLY) as its own best biopharma pick for 2025 as well as measured yet another 9 titles in the space as obese. The financial investment bank said in a note that it continues to feel “diabesity is actually set to become.